Balda AG has acquired HK Plastics Engineering, Inc.
Balda AG (Balda) has acquired 100% of the shares of HK Plastics Engineering, Inc. for an undisclosed consideration.
HK Plastics Engineering, Inc., a family-owned business based in Oceanside, California is a full-service supplier of injection molded plastics and associated molds. It services a range from design and development to tool manufacturing and from the molding process up to mechanical installations. More than 80 percent of its revenue comes from medical customers, especially in the area of medical diagnostics.
Germany-based Balda develops and manufactures high quality plastic systems for medical appliances as well as complete electronic products for communication and entertainment. The Balda medical segment in Bad Oeynhausen develops and produces plastic solutions for the medical technology, pharmaceutical and diagnosis markets.
This acquisition is part of Balda’s buy-and-build strategy for its medical segment. Through this acquisition Balda extends its presence in the strategically important US market and particularly strengthens its medical business.
Oaklins' team in Germany advised Balda in this transaction.
Talk to the deal team
Related deals
Leika Medical Equipments Ltd. has been acquired by Angus Capital
The shareholders of Leika Medical Equipments Ltd. have sold the company to Angus Capital.
Learn morePhen’X Technologies has sold a majority stake to Ciclad
The shareholders of Phen’X Technologies have completed a primary majority LBO with private equity fund Ciclad.
Learn moreMedis Medical Imaging and GE HealthCare announce collaboration focused on non-invasive coronary assessments
Medis Medical Imaging Systems B.V., a leading cardiac imaging software company, have completed a strategic investment to further develop its revolutionary non-invasive cardiovascular imaging solution. The company has announced its collaboration with GE HealthCare (Nasdaq: GEHC), a global leader in medical technology, pharmaceutical diagnostics and innovation in digital solutions, to contribute to the advancement of precision care in the diagnosis and treatment of coronary artery disease (CAD).
Learn more